跳至主要内容
临床试验/NCT02591160
NCT02591160已完成不适用

Optimal Hydrochlorothiazide Cessation in Diagnosis of Hyperparathyroidism

University of Missouri-Columbia2 个研究点 分布在 1 个国家目标入组 2 人开始时间: 2015年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
2
试验地点
2
主要终点
Number of days for Calcium/Creatinine Clearance to normalize after stopping HCTZ

研究概览

简要总结

Primary hyperparathyroidism (PHPT) is the most common cause of hypercalcemia in the ambulatory setting. PHPT may be cured with surgery and indications for intervention have been defined and include urinary calcium/creatinine clearance. Hydrochlorothiazide (HCTZ), the most commonly prescribed medication for hypertension, reduces urinary calcium excretion and confounds urinary testing. As a result, it is universally recommended that thiazide diuretics be stopped in advance of urinary testing. To date, no studies are available to provide evidence-based guidance as to how long HCTZ must be held for urinary calcium excretion to return to steady state in PHPT. The objective of this study is to serially calculate urinary calcium/creatinine clearance ration in patients with suspected PHPT while holding HCTZ to determine the minimum duration of medication cessation necessary for urinary calcium clearance to reach steady state.

详细描述

In this study, adult patients will submit serum and 24 hour urine samples prior to HCTZ cessation and at the following intervals after cessation: 4-6 days, 14-16 days, 28-30 days, adn 90-92 days. To minimize confounding variable, patients will take supplemental Vitamin D and Calcium, monitor their daily calcium intake, and monitor blood pressure weekly. Alternative, non-diuretic, antihypertensive medication(s) may be prescribed at the discretion of the enrolling provider.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Elevated calcium on at least two separate draws with coexistent elevated parathyroid hormone (PTH) on at least one occasion.
  • Taking Hydrochlorothiazide for hypertension
  • Following a "wash period", patients must have a normal range 25-hydroxy Vitamin D level, thyroid stimulation hormone (TSH) and serum magnesium levels.
  • Controlled blood pressure
  • Willingness to comply with serial sampling
  • English as the primary language
  • Adults 18 years and older

排除标准

  • Unable to cease Hydrochlorothiazide for any reason
  • Congestive heart failure
  • Renal insufficiency (GFR <60)
  • Cardiovascular event in the last 3 months - include myocardial infarction, new onset atrial fibrillation, and new onset bundle branch block
  • Take lithium or other diuretic medication in last 3 months
  • Positive family history of familial hypocalciuric hypercalcemia (FHH)

结局指标

主要结局

Number of days for Calcium/Creatinine Clearance to normalize after stopping HCTZ

时间窗: 2-3 years

Determination of the HCTZ cessation window

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Robert P. Zitsch III

William E Davis Professor and Chair

University of Missouri-Columbia

研究点 (2)

Loading locations...

相似试验

Optimal HCTZ Cessation for Diagnosis of... | 临床试验